Omega Healthcare Investors, Inc. reported strong fourth quarter 2024 results with net income of $116 million and Adjusted FFO of $214 million. The company completed $340 million in new investments during the quarter and issued $438 million in equity, while also providing 2025 Adjusted FFO guidance.
Net income for Q4 2024 increased to $116 million, up from $57 million in Q4 2023.
Adjusted FFO for Q4 2024 was $214 million, or $0.74 per common share, compared to $173 million, or $0.68 per common share, for Q4 2023.
The company completed approximately $340 million in new investments in Q4 2024, consisting of $179 million in real estate acquisitions and $162 million in real estate loans.
Omega issued 11 million common shares in Q4 for gross proceeds of $438 million.
The Company expects its 2025 Adjusted FFO to be between $2.90 and $2.98 per diluted share, based on several assumptions including annual impact of acquisitions, asset sales, debt repayments, and no material changes in market interest rates.